Stock Analysis on Net

Amgen Inc. (NASDAQ:AMGN)

$24.99

Selected Financial Data
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Income Statement

Amgen Inc., selected items from income statement, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


The financial data reveals several key trends in the company's performance over the reported periods, specifically focusing on product sales, operating income, and net income figures.

Product Sales
Product sales exhibited a generally upward trajectory from 2005 through 2024, increasing from approximately $12 billion to over $32 billion. Notable growth periods include consistent rises from 2011 to 2014, and again from 2018 onwards. The only slight decreases or plateau phases were observed between 2007 and 2009, and a minor dip around 2018 to 2019. The growth rate accelerated especially in the latter years, indicating robust sales performance and market expansion.
Operating Income
Operating income displayed a more volatile pattern compared to sales. It started at about $4.8 billion in 2005 but declined significantly to around $3.8 billion by 2006 and fluctuated in subsequent years. Peak operating income was observed around 2015 to 2018, reaching close to $10 billion, before experiencing a decline in the following years through 2024. Despite the sales growth, operating income did not consistently track upwards, indicating varying operating efficiency and cost management challenges during some periods.
Net Income
Net income followed a fluctuating path with periods of significant volatility. Starting near $3.7 billion in 2005, net income generally increased with some setbacks. A sharp drop occurred around 2017, registering approximately $2 billion, followed by a recovery peaking around 2018 at over $8 billion. Post-2018, net income again showed a downward trend through 2024. The inconsistency in net income relative to operating income and sales suggests impacts from non-operating factors, tax effects, or extraordinary items affecting profitability.

In conclusion, while product sales demonstrated sustained growth indicative of increasing market demand or product expansion, operating income and net income showed greater fluctuations, reflecting potential challenges in operational efficiency, cost control, or other financial influences. The divergence between sales growth and profitability metrics in some years warrants further detailed examination to understand underlying causes.


Balance Sheet: Assets

Amgen Inc., selected items from assets, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


The financial data indicates notable trends in current assets and total assets over the period from 2005 through 2024. Both metrics display fluctuations as well as distinct growth and decline phases that merit attention.

Current Assets

Current assets showed a general upward trend from 2005 to 2013, increasing from approximately $9.2 billion to a peak near $31.2 billion in 2012, followed by a slight decrease to $27.4 billion in 2013. Thereafter, current assets continued to increase and reached new highs, peaking at about $49.5 billion in 2017. This was followed by a pronounced decline in 2018, falling to roughly $37.6 billion, and a further steep drop in 2019 to approximately $18.4 billion.

In the years following 2019, current assets exhibited some recovery, rising again to over $30 billion in 2023 before slightly declining in 2024 to around $29 billion. These fluctuations suggest periods of significant changes in liquidity or working capital components, potentially reflecting strategic shifts or external economic factors impacting the company’s short-term asset composition.

Total Assets

Total assets consistently increased from 2005 to 2013, growing from nearly $29.3 billion to over $66.1 billion. This growth trajectory continued beyond 2013, albeit with some volatility, reaching approximately $79.9 billion by 2017.

After 2017, total assets experienced a notable downturn, dropping sharply to about $66.4 billion in 2018 and further down to $59.7 billion in 2019. This downward movement was followed by modest recovery and stabilization between 2019 and 2022, with total assets ranging between roughly $61 billion and $65 billion. Subsequently, total assets surged dramatically to approximately $97.2 billion in 2023, before retracting slightly to about $91.8 billion in 2024.

This overall pattern indicates phases of asset expansion coupled with periods of contraction, potentially reflecting acquisition activity, asset impairment, or other large-scale capital management decisions. The substantial increase observed in 2023 could be tied to significant asset acquisitions or revaluations during that year.


Balance Sheet: Liabilities and Stockholders’ Equity

Amgen Inc., selected items from liabilities and stockholders’ equity, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


The financial data reveals notable trends in the company's capital structure and liquidity over the analyzed period. Current liabilities show considerable fluctuation, with an overall upward trajectory. Initial values were relatively moderate but experienced significant increases during certain years, culminating in a sharp rise toward the end of the period. This increase indicates growing short-term obligations and potential pressures on working capital management.

Total debt displays a consistent and marked escalation across the timeline. Beginning at a lower base, the debt load expanded substantially, especially from the early 2010s onward. Despite some fluctuations, the overall trend points to increased leverage, reflecting either strategic borrowing for expansion, acquisitions, or operational financing. The peak occurs near the final years, suggesting an accumulation of financial obligations requiring careful monitoring for sustainability.

Stockholders’ equity presents a contrasting pattern. Initially, equity is relatively strong but demonstrates a declining trend throughout the latter half of the timeframe. There are brief periods of stabilization or minor increases, yet the general direction is downward, particularly pronounced after the mid-2010s. This likely signals challenges in retaining earnings, potential asset impairments, dividend policy impacts, or buybacks influencing the equity base reduction.

Current Liabilities
Overall increase with peaks indicating heightened short-term financial commitments. Fluctuations suggest varying operational cycles or changes in payable management.
Total Debt
Significant upward trend denoting growing leverage, potentially attributable to increased borrowing for corporate activities. Careful attention warranted for debt servicing capacity.
Stockholders’ Equity
Declining trend over the analyzed years, implying reduced net asset value attributable to shareholders. May reflect diminished profitability, equity repurchases, or other equity-reducing events.

The combination of rising liabilities and debt with shrinking equity suggests an increasing reliance on external financing sources and a potential shift towards higher financial risk. This pattern underscores the need for close analysis of cash flows, debt maturity profiles, and capital management strategies to ensure financial stability and long-term shareholder value preservation.


Cash Flow Statement

Amgen Inc., selected items from cash flow statement, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


The analysis of cash flow activities over the examined periods reveals several notable trends and patterns.

Operating Activities

Cash generated from operating activities demonstrates an overall positive and generally increasing trend, reflecting robust core business operations. Starting at approximately $4.9 billion in 2005, the cash inflow grows steadily, peaking around 2013-2014 with values exceeding $8.5 billion. There is a slight decline in some subsequent years, but the inflows remain substantial, with fluctuations that suggest variability in operational performance or working capital management. The most recent years still maintain substantial positive cash flow, with an uptick observed in 2024 to nearly $11.5 billion.

Investing Activities

Cash flows from investing activities are predominantly negative, indicating consistent investments in capital assets, acquisitions, or other long-term assets. Initial outflows are moderate toward 2005-2007 but intensify significantly in certain periods such as 2006, 2012, and notably in 2023, where outflows peak sharply above $26 billion. Interestingly, 2018 shows a positive inflow of $14.3 billion, which may indicate asset disposals, divestitures, or returns from investments. The variability and magnitude of these investing cash flows suggest strategic restructuring or major capital expenditures at different intervals.

Financing Activities

Financing activities exhibit high volatility with both significant inflows and outflows. Early years show moderate cash outflows, reflecting debt repayments, shareholder distributions, or buybacks. Around 2012-2015, outflows worsen markedly, with peaks near $22 billion negative cash flow, indicating heavy debt repayment or dividend activities. However, the period around 2013 and 2023 shows notable positive inflows, possibly from issuing debt or equity financing. The financing cash flow volatility underscores dynamic capital structure management responding to operational and investment funding needs.

Overall, the company maintains strong operational cash generation while actively managing investment and financing cash flows. Investment patterns suggest targeted periods of expansion or asset reallocation, while financing cash flows reflect periods of capital raising and repayment activities, indicating a strategic approach to balancing growth and financial stability.


Per Share Data

Amgen Inc., selected data per share, long-term trends

US$

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1, 2, 3 Data adjusted for splits and stock dividends.


Over the period analyzed, the basic earnings per share (EPS) exhibited a general upward trend with certain fluctuations. Starting at $2.97 in 2005, EPS showed an initial decline through 2006, followed by a moderate recovery reaching a peak of $12.7 in 2018. Despite the overall positive incline, there were noticeable decreases in the years 2012 and 2016, where EPS dropped significantly to $2.71 before rising sharply again. The most recent figures indicate a decrease in basic EPS from $12.56 in 2023 to $7.62 projected for 2024.

The diluted earnings per share followed a pattern similar to the basic EPS, reinforcing the general earnings trajectory noted. This measure began at $2.93 in 2005, dipping slightly in 2006, and then increased reaching a high of $12.62 in 2018. Like basic EPS, it experienced a marked drop in 2016 and a recent decline projected for 2024 at $7.56, down from $12.49 in 2023.

Dividend per share showed a consistent and steady increase from its inception in 2010 at $0.56, rising annually to $9.13 in 2024. This continuous growth in dividends reflects a commitment to returning value to shareholders and suggests confidence in sustained earnings and cash flow generation over the long term.

Profitability Trends
Both basic and diluted EPS demonstrate an overall trend of growth, albeit with volatility at certain points, particularly in 2012 and 2016. This indicates that while the company has generally improved profitability, it has faced periods of earnings pressure.
Dividend Policy
The steadily increasing dividend per share from 2010 onwards indicates a stable and progressively growing return to shareholders. This upward trend in dividends suggests management's positive outlook on future earnings stability and cash flow sufficiency.
Recent Projections
The projected decline in both EPS metrics for 2024 may highlight potential challenges or a conservative earnings outlook for that year. However, the dividend continuation at an increasing rate suggests a cautious but confident approach to shareholder returns despite earnings variability.